Malignant non-Hodgkin's lymphomas in children

Area of Science:

• Pediatric Oncology
• Hematology
• Immunology

Background:

• Childhood non-Hodgkin's lymphomas (NHL) differ from adult forms due to developing immune systems.
• Childhood NHL classification includes lymphoblastic, small noncleaved cell, and large cell types, primarily affecting individuals under 20.

Purpose of the Study:

• To outline the distinct characteristics and epidemiology of childhood non-Hodgkin's lymphomas.
• To detail the histological subtypes, genetic associations, and treatment strategies for pediatric NHL.

Main Methods:

• Histological classification of childhood NHL into lymphoblastic, small noncleaved cell, and large cell types.
• Epidemiological analysis of NHL incidence and geographic distribution.
• Review of treatment modalities, including chemotherapy and central nervous system prophylaxis.

Main Results:

• Lymphoblastic lymphomas are typically immature T-cell origin, while small noncleaved and most large cell lymphomas are B-cell in origin.
• Small noncleaved cell lymphomas present in endemic (Epstein-Barr virus-associated) and sporadic forms with distinct chromosomal translocations.
• Chemotherapy is the primary treatment, with CNS prophylaxis crucial; cure rates are high for limited disease but lower for extensive or bone marrow involvement.

Conclusions:

• Childhood NHL is a distinct entity requiring specific diagnostic and therapeutic approaches.
• Understanding the subtypes and genetic factors of pediatric NHL is key to improving outcomes.
• Modern chemotherapy and CNS prophylaxis offer high cure rates for most childhood NHL cases, though bone marrow involvement remains a challenge.